Managers / Q1 2024 · view latest →
HARBOURVEST PARTNERS LLC
CIK 0001201001 · ONE LINCOLN STREET, SUITE 1700, BOSTON, MA, 02111 · 617-348-3707
Summary
Harbourvest Partners LLC reported $219M in U.S.-listed holdings across 48 positions for Q1 2024.
The portfolio is heavily concentrated: W alone accounts for 32.9% of reported value.
Compared with Q4 2023, the fund opened 0 new positions and exited 5.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 89.4% · $196M
- Other · 6.0% · $13M
- ADR · 4.6% · $10M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| COINCoinbase Global Inc. | SOLD OUT | −157.2K | 0 | −$27M | $0 |
| CRGYCrescent Point Corp. | SOLD OUT | −1.68M | 0 | −$12M | $0 |
| SPOTSpotify Technology S.A. | SOLD OUT | −16.8K | 0 | −$3M | $0 |
| FROGJfrog Ltd. | SOLD OUT | −54.0K | 0 | −$2M | $0 |
| SANASana Biotechnology, Inc. | SOLD OUT | −117.7K | 0 | −$480,192 | $0 |
| MNDYmonday.com Ltd. | TRIMMED | −172.1K | 9.9K | −$32M | $2M |
| AFRMAffirm, Inc. | ADDED | +15.4K | 38.6K | +$299,411 | $1M |
| NABLN-Able, Inc. | TRIMMED | −1.61M | 1.29M | −$22M | $17M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2024
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | WWayfair Inc.history → | Common CLA | 32.88% | $72M | 1.06M |
| 2 | TOSTToast, Inc.history → | Common CLA | 25.94% | $57M | 2.28M |
| 3 | NABLN-Able, Inc.history → | Common | 7.71% | $17M | 1.29M |
| 4 | Omega Therapeutics, Inc. | Common | 5.85% | $13M | 3.51M |
| 5 | YMMFull Truck Alliance Co. Ltd.history → | Sponsored ADS | 3.17% | $7M | 957.6K |
| 6 | HashiCorp, Inc. | Common CLA | 2.57% | $6M | 209.3K |
| 7 | LendingClub Corp. | Common NEW | 2.06% | $5M | 513.4K |
| 8 | PGNYProgyny, Inc.history → | Common | 1.56% | $3M | 89.7K |
| 9 | HSAIHesai Grouphistory → | Sponsored ADS | 1.40% | $3M | 606.1K |
| 10 | RLAYRelay Therapeutics, Inc.history → | Common | 1.12% | $2M | 296.4K |
| 11 | MNDYmonday.com Ltd.history → | SHS | 1.02% | $2M | 9.9K |
| 12 | ACVAACV Auctions, Inc. | Common CLA | 0.97% | $2M | 113.1K |
| 13 | HNSTHonest Company Inc. | Common | 0.88% | $2M | 475.6K |
| 14 | Olo, Inc. | Common CLA | 0.86% | $2M | 341.8K |
| 15 | Inari Medical | Common | 0.84% | $2M | 38.5K |
| 16 | BEBloom Energy Corporation | Common CLA | 0.83% | $2M | 162.2K |
| 17 | IBRXImmunityBio, Inc. | Common | 0.82% | $2M | 335.7K |
| 18 | DOCNDigitalOcean, Inc. | Common | 0.77% | $2M | 44.2K |
| 19 | AMPLAmplitude Inc. | Common CLA | 0.76% | $2M | 153.0K |
| 20 | Zuora, Inc. | Common CLA | 0.68% | $1M | 163.9K |
| 21 | COURCoursera, Inc. | Common | 0.68% | $1M | 106.1K |
| 22 | PATHUiPath, Inc. | Common CLA | 0.66% | $1M | 63.7K |
| 23 | AFRMAffirm, Inc. | Common CLA | 0.66% | $1M | 38.6K |
| 24 | DOCSDoximity, Inc. | Common CLA | 0.61% | $1M | 49.8K |
| 25 | DIBS1stdibs.com, Inc. | Common | 0.54% | $1M | 199.5K |
| 26 | HOODRobinhood Markets Inc. | Common CLA | 0.47% | $1M | 50.7K |
| 27 | IASIntegral Ad Science, Inc. | Common | 0.42% | $915,037 | 91.8K |
| 28 | UUnity Software | Common | 0.42% | $912,980 | 34.2K |
| 29 | TWLOTwilio, Inc. | Common CLA | 0.41% | $891,078 | 14.6K |
| 30 | PINSPinterest, Inc. | Common CLA | 0.34% | $738,818 | 21.3K |
| 31 | PLRXPliant Therapeutics, Inc. | Common | 0.34% | $736,567 | 49.4K |
| 32 | SONDQSonder Holdings, Inc. | CL A NEW | 0.30% | $666,332 | 225.1K |
| 33 | GTMZoomInfo Technologies Inc | Common | 0.28% | $620,249 | 38.7K |
| 34 | Eventbrite, Inc. | Common CLA | 0.26% | $559,859 | 102.2K |
| 35 | CPNGCoupang Inc. | Common CLA | 0.22% | $477,377 | 26.8K |
| 36 | QSQuantumScape Corporation | Common CLA | 0.16% | $355,379 | 56.5K |
| 37 | DASHDoorDash, Inc. | Common CLA | 0.16% | $344,989 | 2.5K |
| 38 | NeueHealth, Inc. | Common NEW | 0.16% | $342,680 | 52.7K |
| 39 | OPENOpendoor Technologies Inc. | Common | 0.06% | $141,522 | 46.7K |
| 40 | IPSCCentury Therapeutics, Inc. | Common | 0.06% | $121,295 | 29.0K |
| 41 | PACBPacific Biosciences of California, Inc. | Common | 0.04% | $88,065 | 23.5K |
| 42 | RPTXRepare Therapeutics, Inc. | Common | 0.03% | $57,820 | 12.3K |
| 43 | Rallybio Holdings, LLC | Common | 0.02% | $40,472 | 21.9K |
| 44 | Seres Therapeutics, Inc. | Common | 0.02% | $38,212 | 49.4K |
| 45 | NextCure, Inc. | Common | 0.01% | $22,398 | 10.0K |
| 46 | PMVPPMV Pharmaceuticals | Common | 0.01% | $19,606 | 11.5K |
| 47 | Aligos Therapeutics, Inc. | Common | 0.01% | $18,407 | 18.8K |
| 48 | Astra Space, Inc. | CL A NEW | 0.00% | $8,487 | 12.4K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $101M | 5 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $174M | 7 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $205M | 9 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $91M | 15 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $154M | 16 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $203M | 22 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $192M | 34 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $188M | 40 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $219M | 48 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $299M | 53 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $295M | 58 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $352M | 60 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $297M | 63 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $299M | 65 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $306M | 67 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $305M | 62 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $490M | 66 | May 26, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2021 | $782M | 67 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.1B | 56 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $1.0B | 51 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $746M | 44 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $256M | 26 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $270M | 36 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $232M | 28 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $207M | 36 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $243M | 35 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $240M | 33 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $262M | 32 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $283M | 33 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $211M | 32 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.